The faster the better: Anastomosis time influences patient survival after deceased donor kidney transplantation

Transplant International

Volumn 28, Issue 5, 2015, Pages 535-543

  Weissenbacher, Annemarie ^a   Oberhuber, Rupert ^a   Cardini, Benno ^a   Weiss, Sascha ^a   Ulmer, Hanno ^a   Bösmüller, Claudia ^a   Schneeberger, Stefan ^a   Pratschke, Johann ^a,b   Öllinger, Robert ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

anastomosis time; deceased donor; graft survival; kidney transplantation; patient survival

Indexed keywords

ADULT; ANASTOMOSIS; ANASTOMOSIS TIME; ARTICLE; BRAIN HEMORRHAGE; CADAVER DONOR; CEREBROVASCULAR ACCIDENT; CHRONIC GRAFT REJECTION; CHRONIC PATIENT; FEMALE; GRAFT INFECTION; GRAFT SURVIVAL; HEART FAILURE; HUMAN; KAPLAN MEIER METHOD; KIDNEY ALLOGRAFT; LIVER FAILURE; LONG TERM SURVIVAL; LUNG INFECTION; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; BODY MASS; COLD ISCHEMIA; DONOR; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MORTALITY; PROCEDURES; TIME; TREATMENT OUTCOME;

ADULT; ANASTOMOSIS, SURGICAL; BODY MASS INDEX; COLD ISCHEMIA; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84928362038     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12516     Document Type: Article

References (35)

1. Lamb KE, Lodhi S, Meier-Kriesche HU,. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2012; 11: 450.
2. Legendre C, Canaud G, Martinez F,. Factors influencing long-term outcome after kidney transplantation. Transpl Int 2014; 27: 19.
3. Lancet T,. Urgently needed: a framework convention for obesity control. Lancet 2011; 378: 741.
4. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL,. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
5. Lebranchu Y, Halimi JM, Bock A, et al.,. Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST. A multinational observational study. Transplant Proc 2005; 37: 345.
6. Van der Vliet JA, Warlé MC, Cheung CL, Teerenstra S, Hoitsma AJ,. Influence of prolonged cold ischemia in renal transplantation. Clin Transplant 2011; 25: 612.
7. Siedlecki A, Irish W, Brennan DC,. Delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279.
8. Roodnat JI, Mulder PG, Van Riemsdijk IC, IJzermans JN, van Gelder T, Weimar W,. Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation 2003; 75: 799.
9. Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC,. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10: 2279.
10. Marzouk K, Lawen J, Alwayn I, Kiberd BA,. The impact of vascular anastomosis time on early kidney transplant outcomes. Transplant Res 2013; 2: 8.
11. Hellegering J, Visser J, Kloke HJ, et al.,. Deleterious influence of prolonged warm ischemia in living donor kidney transplantation. Transplant Proc 2012; 44: 1222.
12. Brezger A, Lang S,. Generalized structured additive regression based on Bayesian P-splines. Computational statistics & data. Analysis 2006; 50: 947.
13. Eltzschig HK, Eckle T,. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391.
14. Pascual J, Zamora J, Pirsch JD,. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008; 52: 553.
15. Rech TH, Moraes RB, Crispim D, Czepielewski MA, Leitáo CB,. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation 2013; 95: 966.
16. Bahde R, Vowinkel T, Unser J, et al.,. Prognostic factors for kidney allograft survival in the Eurotransplant Senior Program. Ann Transplant 2014; 19: 201.
17. Schold JD, Buccini LD, Srinivas TR, et al.,. The association of center performance evaluations and kidney transplant volume in the United States. Am J Transplant 2013; 13: 67.
18. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU,. The broad spectrum of quality in deceased donor kidneys. Am J Transplant 2005; 5: 757.
19. Gondos A, Döhler B, Brenner H, Opelz G,. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 2013; 95: 267.
20. Vincenti F, Charpentier B, Vanrenterghem Y, et al.,. A Phase III study of belatacept-based immunosuppression regimens vs cyclosporine in renal transplant recipients (BENEFIT Study). Am J Transplant 2010; 10: 535.
21. Charpentier B, Medina Pestana JO, del C Rial M, et al.,. Long-term exposure to belatacept in recipients of extended criteria donor kidneys. Am J Transplant 2013; 13: 2884.
22. Ojo AO, Hanson JA, Meier-Kriesche H, et al.,. Survival in recipients of marginal cadaveric donor kidney compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589.
23. Port FK, Bragg-Gresham JL, Metzger RA, et al.,. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
24. Lu YP, Chen WG, Wang I, Li YP,. A new rat model of transplant arteriosclerosis accelerated by ischemia/reperfusion injury. Transplant Proc 2003; 35: 184.
25. O'Callaghan JM, Morgan RD, Knieght SR, Morris PJ,. Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes. Br J Surg 2013; 100: 991.
26. Schumacher M, Van Vliet BN, Ferrari P,. Kidney transplantation in rats: an appraisal of surgical techniques and outcome. Microsurgery 2003; 23: 387.
27. Thompson RH, Lane BR, Lohse CM, et al.,. Every minute counts wehn the renal hilum is clamped during partial nephrectomy. Eur Urol 2010; 58: 340.
28. Powell JT, Tsapepas DS, Martin ST, Hardy MA, Ratner LE,. Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline. Clin Transplant 2013; 27: 484.
29. McDaniel DO, Rigney DA, McDaniel KY, et al.,. Early expression profile of inflammatory markers and kidney allograft status. Transplant Proc 2013; 45: 1520.
30. Asgari E, Farrar CA, Lynch N, et al.,. Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4. FASEB J 2014; 28: 3996.
31. Cavaillé-Coll M, Bala S, Velidedeoglu E, et al.,. Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am J Transplant 2013; 13: 1134.
32. Thierry A, Giraud S, Robin A, et al.,. The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33. PLoS One 2014; 9: e88742.
33. Stallone G, Infante B, Gesualdo L,. Oder donors and older recipients in kidney transplantation. J Nephrol 2010; 23: 98.
34. Watson CJ, Johnson RJ, Birch R, Collett D, Bradley JA,. A simplified donor risk index for predicting outcome after deceased donor kidney transplantation. Transplantation 2012; 93: 314.
35. Rao PS, Schaubel DE, Guidinger MK, et al.,. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009; 88: 231.